UPC CFI 382/2025
Apr 29, 2025·EP2501384 · METHOD OF TREATING PROLIFERATIVE DISORDERS AND OTHER PATHOLOGICAL CONDITIONS MEDIATED BY BCR-ABL, C-KIT, DDR1, DDR2 OR PDGF-R KINASE ACTIVITY
- Case details
- StatusCase ClosedActionGenericCategoryCosts assessments
- Parties
- Respondents
- Zentiva, k.s.Operating co.
- ZENTIVA PORTUGAL, LDAOperating co.
Representatives- Marc Lauzeral-Schertenleib
- Schertenleib
- Division
- Milan CD
- Technology
- ChemistryOrganic fine chemistry · Pharmaceuticals
- Language
- English
- EPO Opposition
- Fresenius Kabi Deutschland GmbHAdmissible2016-11-14
- Hamm&Wittkopp Patentanwälte PartmbBAdmissible2016-11-17
- Teva Pharmaceutical Industries LtdAdmissible2016-11-17
- Intas Pharmaceuticals Ltd.Admissible2016-11-17
- Generics (U.K.) LimitedAdmissible2016-11-17
- TEVA PHARMACEUTICAL INDUSTRIES, LTD.Admissible2016-11-17
| Median days to first decision | |
|---|---|
| All UPC | 124 |
| Milan CD | Locked |
| Judge Andrea Postiglione | Locked |
| Judge Marije Knijff | Locked |
| Judge Oliver Werner | Locked |
At the UPC: Novartis AG (4 cases)·Zentiva Group (15 cases)
This dispute contains 1 other proceedings
- 2025-07-31Application For CostsPublic
Summary: Decision on costs from the Milan Central Division dated 31 July 2025 in proceedings where Novartis AG sought reimbursement of costs from Zentiva K.S. and Zentiva Portugal Lda following the dismissal of Zentiva's revocation action against EP 2 501 384. The court dismissed Novartis' costs application because Novartis failed to comply with the court's request under R. 156.1 RoP to provide substantiated evidence of costs (itemised hourly rates and hours), instead providing only a sworn general statement. The court held that: (1) once a R. 156.1 request is issued, costs can no longer be assessed equitably but only on proof; (2) confidentiality cannot be invoked to withhold cost information from the court; (3) costs for legal representation are not per se confidential under R. 262A RoP.
Show the legal issues (3)
- Standard of proof for cost reimbursement after R. 156.1 RoP request
- Confidentiality of legal cost information
- Equitable assessment of costs versus proof-based assessment
| Document title | Date | Public |
|---|---|---|
| Case Closure Formal Check | 2025-08-20 | Not public |
| Headnote-and-Keywords | 2025-07-31 | Not public |
| Application-For-Costs-Decision-Outcome | 2025-07-31 | Not public |
| DECISION | 2025-07-31 | Public |
| 20250609 Cost recovery observations No 2 pdf a signee | 2025-06-09 | Not public |
| 20250609 Cost recovery observations No 2 pdf a signee | 2025-06-09 | Not public |
| 2025 06 03 - Comments on Submission by Zentiva | 2025-06-03 | Not public |
| Outcome of the Order | 2025-06-03 | Not public |
| ORDER 3 JUNE | 2025-06-03 | Public |
| ORDER 3 JUNE | 2025-06-03 | Public |